TransCode Therapeutics Revenue

Biotechnology Research • Newton, Massachusetts, United States • 11-20 Employees

TransCode Therapeutics revenue & valuation

Annual revenue	$1,197,770
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,900,000
Total funding	$31,500,000

Key Contacts at TransCode Therapeutics

Philippe Calais

Chairman Of The Board Of Directors, Transcode Therapeutics Nasdaq: Rnaz

Elizabeth Adkins Czerepak

Chairman Of Audit Committee, Board Of Directors

Erik Manting

Independent Director

Zdravka Medarova

Chief Technology Officer

Tom Fitzgerald

Chief Financial Officer; Director

Lisa Fortin

Director Clinical Operations

Tania Montgomery

Director Bd

Company overview

Headquarters	73b Chapel St, Newton, Massachusetts 02458, US
Website	transcodetherapeutics.com
NAICS	541714
SIC	283
Keywords	RNA, Diagnostics, Oncology, Crispr, Metastasis, Orphan Disease Designation, Nucleic Acid Therapeutics, Checkpoint Inhibitor, Pattern Recognition Receptor, Mrna Vaccine
Founded	2016
Employees	11-20
Socials

TransCode Therapeutics Email Formats

TransCode Therapeutics uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@transcodetherapeutics.com), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@transcodetherapeutics.com	100%

About TransCode Therapeutics

TransCode's goal is delivering a cancer-free future for all cancer patients. Our core belief is that cancer can be overcome through the intelligent design and efficient delivery of targeted therapeutics. Our lead therapeutic candidate, TTX-MC138, targets microRNA-10b, or miRNA-10b, considered the master regulator of metastatic cell viability in a range of cancers, including breast, pancreatic, ovarian, colon cancer, glioblastomas, and several others. TransCode believes it has overcome this barrier, opening the door to a broad array of cancer therapies -- a disease with the highest unmet need that affects everyone. It is through the design and optimization of this technology that TransCode has devised an elegant solution -- TTX -- a proprietary delivery platform for the transport of targeted therapeutics to cancer cells. With their world class team and know how, TransCode has a rapidly expanding platform of drug candidates designed to target a variety of tumor indications with the goal of long-term treatment survival. Important Notice: Recruitment Fraud Alert We are aware of recruitment scams in which fraudsters pose as representatives of TransCode Therapeutics to deceive job seekers. Please note the following to protect yourself: • We NEVER ask for payment or personal financial information during the recruitment process. • All legitimate communication from our team will come from an official @transcodetherapeutics.com email address • Our hiring process always includes formal interviews—either virtual or in-person. • If you receive a job offer claiming to be from us, please do NOT respond. Report it to info@transcodetherapeutics.com.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

C-Suite

Director

Partner

Employees by Department

TransCode Therapeutics has 5 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore TransCode Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2023-12-30	14	$1,200,000
2024-02-18	14	$7,300,000
2024-08-22	14	$3,000,000
2024-10-05	9	$2,000,000
2024-12-27	14	$8,000,000
2025-04-23	14	$10,000,000

Funding Insights

$31,500,000

Total funding amount

$10,000,000

Most recent funding amount

Number of funding rounds

TransCode Therapeutics Tech Stack

Discover the technologies and tools that power TransCode Therapeutics's digital infrastructure, from frameworks to analytics platforms.

MediaElement.js

Video players

reCAPTCHA

Security

Cloudflare Bot Management

Security

Vimeo

Video players

Microsoft 365

Cloudflare

CDN

jQuery

JavaScript libraries

Weebly

CMS

Hammer.js

JavaScript libraries

PHP

Programming languages

Google Analytics

Analytics

Adobe Fonts

Font scripts

Frequently asked questions

TransCode Therapeutics is located in Newton, Massachusetts, US.

TransCode Therapeutics generates an estimated annual revenue of $1,197,770. This revenue figure reflects the company's market position and business performance in its industry.

TransCode Therapeutics has an estimated valuation of $3,900,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

TransCode Therapeutics was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

TransCode Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

TransCode Therapeutics has raised a total of $31,500,000 across 6 funding rounds. This investment has helped the company grow and expand its operations.